Clinical Trials on Dyskinesia in Australia

Total 116 results

ReCode Therapeutics

Recruiting

Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

Primary Ciliary Dyskinesia

United Kingdom, United States, Australia, New Zealand
The Bionics Institute of Australia

Recruiting

The Development of a System for the Measurement of Tremor

Tremor

Australia
Novartis Pharmaceuticals

Completed

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Parkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia Agents

Spain, United States, Austria, Switzerland, France, Germany, Italy, Canada, Hungary, Slovakia
Newron Pharmaceuticals SPA

Completed

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects (Safinamide-LID)

Parkinson's Disease

Austria, Canada, France, Germany, South Africa
Allergan

Completed

Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia

Spasmodic Torticollis

Poland, Turkey, Italy, Croatia, Australia
Novartis Pharmaceuticals

Completed

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Parkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia Agents

Spain, United States, Austria, Switzerland, France, Germany, Italy, Hungary, Canada, Slovakia
Medy-Tox

Completed

Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

Cervical Dystonia

Australia
Adamas Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia (EASE LID 3)

Parkinson's Disease (PD) | Dyskinesia | Levodopa-Induced Dyskinesia (LID)

France, Spain, United States, Germany, Austria
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Validation of Dyskinesia Rating Scales

Parkinson's Disease

United States, Austria, Canada, France
Novartis Pharmaceuticals

Completed

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Parkinson Disease | Dyskinesia, Drug-Induced | Levodopa

Italy, United States, Australia, France, Germany, Canada
Royal Victoria Eye and Ear Hospital
The Florey Institute of Neuroscience and Mental Health

Active, not recruiting

The Development of a System for Measurement of Tremor

Dystonia | Essential Tremor

Australia
Impel Pharmaceuticals

Completed

Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101 (SNAP101)

Acute Agitation

Australia
Bionomics Limited

Completed

A Study of BNC210 in Elderly Patients With Agitation

Agitation in the Elderly

Australia
The University of Western Australia

Completed

Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor

Parkinson's Disease | Tremor

Australia
Adamas Pharmaceuticals, Inc.

Completed

Open-Label Safety Study of ADS-5102 in PD Patients With LID

Parkinson's Disease (PD) | Dyskinesia | Levodopa Induced Dyskinesia (LID)

France, Spain, United States, Canada, Germany, Austria
Novartis

Completed

Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Parkinson Disease | Dyskinesias

Italy, Spain, France, Germany, Finland, Japan, Australia, Canada
Allergan

Terminated

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

Spasmodic Torticollis

Argentina, India, Australia
Addex Pharma S.A.

Completed

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

Parkinson's Disease

United States, Austria, France, Germany
Melbourne Health
Eastern Health

Completed

The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor

Multiple Sclerosis | Tremor

Australia
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Adult Attention-deficit Hyperactivity Disorder (ADHD)

Australia
MED-EL Elektromedizinische Geräte GesmbH

Recruiting

Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50) (ECE50)

Laryngeal Dystonia | Vocal Fold Paresis

Austria
Kirsten Elwischger

Completed

Static Graviceptive Functions in Patients With Cervical Dystonia (CD)

Cervical Dystonia

Austria
Warner Chilcott

Completed

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder (HSDD)

United States, Australia, Canada
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

United States, Canada, Australia
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Canada, Australia, United States
Medical University of Graz

Enrolling by invitation

Identifying Markers of Disease Subtypes and Disease Progression in the Syndrome of Essential Tremor

Essential Tremor

Austria
Warner Chilcott

Completed

Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen

Hypoactive Sexual Desire Disorder

Australia, Botswana, Canada, Germany, United Kingdom
Ipsen

Completed

Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm] (CDNISLongterm)

Cervical Dystonia

Austria, Germany
Murdoch Childrens Research Institute

Active, not recruiting

Micronised Resveratrol as a Treatment for Friedreich Ataxia

Friedreich Ataxia

Australia
Prof. Dr. Matthis Synofzik

Recruiting

RFC1 Natural History Study (RFC1-NHS)

Ataxia

Germany, Italy, Australia, Brazil, France, New Zealand, Turkey
Murdoch Childrens Research Institute
Friedreich's Ataxia Research Alliance

Completed

A Study of Resveratrol as Treatment for Friedreich Ataxia

Friedreich Ataxia

Australia
Western Sydney Local Health District
Monash University; University of Sydney; University of Melbourne; The University... and other collaborators

Not yet recruiting

A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers (NAC-preHD)

Huntington Disease

Australia
The University of Queensland
National Health and Medical Research Council, Australia

Completed

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis (A-TC7)

Ataxia Telangiectasia

Australia
The University of Queensland

Not yet recruiting

Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside (ATNAD)

Ataxia Telangiectasia

Australia
Medical University of Vienna

Completed

The Serotonin Transporter in Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Austria
Praxis Precision Medicines
Praxis Precision Medicines Australia Pty Ltd

Completed

A Clinical Trial of PRAX-944 in Participants With Essential Tremor

Essential Tremor

United States, Australia, New Zealand
Starship Child Health, Te Toka Tumai Auckland
Menzies School of Health Research; Health Research Council, New Zealand

Not yet recruiting

TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children (TREAT-SC)

Rheumatic Fever | Sydenham Chorea

Australia, New Zealand
Reata, a wholly owned subsidiary of Biogen
AbbVie; Friedreich's Ataxia Research Alliance

Active, not recruiting

RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe

Friedreich Ataxia

United States, Australia, Austria, Italy, United Kingdom
German Parkinson Study Group (GPS)
Medtronic; Competence Network on Parkinson's Disease

Unknown

Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia

Dystonia

Germany, Austria
Eli Lilly and Company

Completed

Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) (ADHD SWITCH)

Attention Deficit Hyperactivity Disorder

Australia, United Kingdom, Mexico
Ipsen

Completed

Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia

Cervical Dystonia

France, Belgium, Czechia, Australia, Poland, Portugal, Ukraine, Hungary, Russian Federation, Austria, Germany
German Parkinson Study Group (GPS)
Medtronic; Competence Network on Parkinson's Disease

Completed

Double-blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical Dystonia

Cervical Dystonia

Austria, Germany
ApoPharma

Completed

A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia

Friedreich's Ataxia

Canada, Australia, Belgium, France, Italy, Spain
Medical University of Graz

Recruiting

Observational Study on "Functional Overlay" in Patients With Movement Disorders

Parkinson Disease | Dystonia | Conversion Disorder | Tremor

Austria
BRC Operations Pty. Ltd.

Unknown

International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder

Attention Deficit/Hyperactivity Disorder

United States, Australia, Netherlands
PTC Therapeutics

Recruiting

An Extension Study to Evaluate the Long-Term Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

Huntington Disease

Australia, France, Germany, Netherlands, United Kingdom, Spain, Austria, Canada, Italy, New Zealand
Ataxia Study Group
German Center for Neurodegenerative Diseases (DZNE)

Recruiting

Sporadic Degenerative Ataxia With Adult Onset: Natural History Study (SPORTAX-NHS)

Late Onset Sporadic Cerebellar Ataxia

Norway, Austria, Germany, Netherlands, Italy
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Monash University
Children's Hospital of Philadelphia; McGill University; University of Florida; University... and other collaborators

Active, not recruiting

A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals With Friedreich Ataxia (TRACK-FA) ((TRACK-FA))

Friedreich Ataxia

United States, Canada, Australia, Brazil, Germany
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland

Clinical Trials on Dyskinesia in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations